The human non-muscle α-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells

Sotiris N. Nikolopoulos(State University of New York), Robert A. Ross(Virginia Technologies (United States)), Kristin D. Kisselbach(Teva Pharmaceuticals (Czechia)), June L. Biedler(Memorial Sloan Kettering Cancer Center), Barbara A. Spengler, Audrey E. Evans(Purdue University West Lafayette)
Oncogene
January 20, 2000
10.1038/sj.onc.1203310
Cited by 77

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583